Counter-intuitive plasma vitamin D and zinc status in HIV-1-infected adults with persistent low-level viraemia after treatment initiation: a pilot case–control study

[1]  E. Ribera,et al.  Very low level viraemia and risk of virological failure in treated HIV‐1‐infected patients , 2017, HIV medicine.

[2]  R. Bollinger,et al.  25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings. , 2014, The Journal of infectious diseases.

[3]  L. Vandekerckhove,et al.  Markers associated with persisting low-level viraemia under antiretroviral therapy in HIV-1 infection. , 2014, The Journal of antimicrobial chemotherapy.

[4]  H. Trottier,et al.  Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  P. Borel,et al.  Bioavailability of vitamin E in humans: an update. , 2013, Nutrition reviews.

[6]  P. Chauvin,et al.  Prevalence and socioeconomic and geographical inequalities of household food insecurity in the Paris region, France, 2010 , 2013, BMC Public Health.

[7]  G. Fattovich,et al.  Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon‐based antiviral therapy , 2013, Hepatology.

[8]  J. Sánchez-Payá,et al.  Low-Level HIV Viremia Is Associated With Microbial Translocation and Inflammation , 2013, Journal of acquired immune deficiency syndromes.

[9]  M. Haskell.  The challenge to reach nutritional adequacy for vitamin A: β-carotene bioavailability and conversion--evidence in humans. , 2012, The American journal of clinical nutrition.

[10]  S. Spector,et al.  Toll-Like Receptor 8 Ligands Activate a Vitamin D Mediated Autophagic Response that Inhibits Human Immunodeficiency Virus Type 1 , 2012, PLoS pathogens.

[11]  C. Delpierre,et al.  High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. , 2012, The Journal of antimicrobial chemotherapy.

[12]  M. Netea,et al.  Seasonal Variation in Vitamin D3 Levels Is Paralleled by Changes in the Peripheral Blood Human T Cell Compartment , 2012, PloS one.

[13]  R. Haubrich,et al.  Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy. , 2011, The Journal of infectious diseases.

[14]  M. Touvier,et al.  Determinants of serum zinc concentrations in a population of French middle-age subjects (SU.VI.MAX cohort) , 2010, European Journal of Clinical Nutrition.

[15]  H. Bischoff-Ferrari,et al.  High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients , 2010, AIDS.

[16]  C. Geisler,et al.  Vitamin D controls T cell antigen receptor signaling and activation of human T cells , 2010, Nature Immunology.

[17]  T. Brown,et al.  Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D , 2010, Antiviral therapy.

[18]  D. Pillay,et al.  Causes and Consequences of Incomplete HIV RNA Suppression in Clinical Trials , 2009, HIV clinical trials.

[19]  M. Holick,et al.  Vitamin D status: measurement, interpretation, and clinical application. , 2009, Annals of epidemiology.

[20]  Pablo Barreiro,et al.  Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome. , 2008, The Journal of antimicrobial chemotherapy.

[21]  S. Tenbaum,et al.  Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3. , 2007, Journal of molecular endocrinology.

[22]  D. Spiegelman,et al.  Micronutrient Levels and HIV Disease Status in HIV-Infected Patients on Highly Active Antiretroviral Therapy in the Nutrition for Healthy Living Cohort , 2006, Journal of acquired immune deficiency syndromes.

[23]  R. D'Agostino.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. , 2005, Statistics in medicine.

[24]  Z. Grossman,et al.  Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia , 2004, AIDS.

[25]  A. Schnitzler,et al.  Retinoid-Dependent Restriction of Human Immunodeficiency Virus Type 1 Replication in Monocytes/Macrophages , 2004, Journal of Virology.

[26]  Judith Chwalow,et al.  Impact of a patient education program on adherence to HIV medication: a randomized clinical trial. , 2003, Journal of acquired immune deficiency syndromes.

[27]  H. Lai,et al.  Zinc status in human immunodeficiency virus type 1 infection and illicit drug use. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  L. Cuzin,et al.  [NADIS 2000, development of an electronic medical record for patients infected by HIV, HBV and HCV]. , 2003, Presse medicale.

[29]  K. Radimer.  Measurement of household food security in the USA and other industrialised countries , 2002, Public Health Nutrition.

[30]  W. Bilker,et al.  Effect of adherence to newly initiated antiretroviral therapy on plasma viral load , 2001, AIDS.

[31]  M. Lederman,et al.  Immune restoration with antiretroviral therapies: implications for clinical management. , 2000, JAMA.

[32]  P. Kissinger,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. , 1998, The New England journal of medicine.

[33]  S. Coniglio,et al.  Retinoid-Induced Repression of Human Immunodeficiency Virus Type 1 Core Promoter Activity Inhibits Virus Replication , 1998, Journal of Virology.

[34]  G. Satten,et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.

[35]  A. Saah,et al.  Association between serum vitamin A and E levels and HIV‐1 disease progression , 1997, AIDS.

[36]  M S Lewis,et al.  Zn2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro. , 1997, Biochemistry.

[37]  J. Buring,et al.  Micronutrients and HIV‐1 disease progression , 1995, AIDS.

[38]  John W. Ward,et al.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[39]  F. Aillet,et al.  Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines. , 1992, Journal of immunology.

[40]  M. Meltzer,et al.  Enhanced HIV-1 replication in retinoid-treated monocytes. Retinoid effects mediated through mechanisms related to cell differentiation and to a direct transcriptional action on viral gene expression. , 1992, Journal of immunology.

[41]  A. Tomasselli,et al.  Zinc inhibition of renin and the protease from human immunodeficiency virus type 1. , 1991, Biochemistry.

[42]  M. Hirsch,et al.  Enhancement of human immunodeficiency virus 1 replication in monocytes by 1,25-dihydroxycholecalciferol. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[43]  G. Craig,et al.  An inverse relationship between serum zinc and C-reactive protein levels in acutely ill elderly hospital patients. , 1990, Postgraduate medical journal.

[44]  A. Aplogan,et al.  From the Centers for Disease Control and Prevention , 2015 .

[45]  From the Centers for Disease Control and prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, JAMA.

[46]  W. Willett,et al.  Relationship of serum copper and zinc levels to HIV-1 seropositivity and progression to AIDS. , 1991, Journal of acquired immune deficiency syndromes.

[47]  C. Keen,et al.  Zinc status in human immunodeficiency virus infection. , 1990, Life sciences.